Advertisement

Combo Treatment With Xalnesiran Shows Promise in Patients With Hep B

0

Highest percentage of patients with HBsAg loss after end of treatment for those receiving xalnesiran + immunomodulator

Transmission of RV5 Strain Occurs Infrequently in Neonatal ICU

0

Estimated rate of transmission was 2.2 per 1,000 patient-days at risk; no gastroenteritis symptoms seen in transmission cases

1990 to 2021 Saw Decline in Life Expectancy in the United States

0

Rankings of life expectancy and healthy life expectancy declined for males and females in the United States

Clinical Practice Guideline Updated for Radiation Therapy for Rectal Cancer

0

Neoadjuvant RT strongly recommended for stage II to III rectal cancer but can be omitted for those at lower risk for locoregional recurrence

Hypovolemic Phlebotomy Beneficial Before Liver Resection

0

Hypovolemic phlebotomy reduces perioperative red blood cell transfusions, with no increase in incidence of complications

Health Span-Lifespan Gaps Widening Globally

0

Sex difference identified, with women exhibiting a wider health span-lifespan gap than men

Screening Primary Driver of Averted Cancer Deaths From 1975 to 2020

0

Authors say further reductions will require new discoveries, adoption of emerging interventions

Celiac Disease Linked to Higher Risk for Developing Alopecia Areata

0

Risk 25 percent higher when comparing matched individuals with and without celiac disease

Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC

0

Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer

EPA Bans Two Solvents Linked to Cancer

0
By Robin Foster HealthDay Reporter MONDAY, Dec. 9, 2024 (HealthDay News) -- Two commonly used solvents that have been linked to cancer were banned Monday...